Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Complications of untreated hypogammaglobulinemia in a patient with common variable immunodeficiency – A case report
Grochowalska, Kinga , Ziętkiewicz, Marcin , Dulski, Jarosław , Suchanek, Hanna, Jaskólska, Marta , Dulski, Jaroslaw , Sławek, Jarosław

International Journal of Immunopathology and Pharmacology | October 16, 2024 | Volume: 38 | Issue: No issue available | Pages: No page available

10.1177/03946320241282957 Get It

Common variable immunodeficiency (CVID) is a primary immunodeficiency disorder characterized by decreased or undetectable serum levels of immunoglobulin G (IgG), decreased levels of IgA isotypes, and poor specific antibody production in response to vaccines and pathogens. Owing to hypogammaglobulinemia, patients have increased susceptibility to infections and a higher risk of malignancies. Here we present a case study of patient with a diagnosis of CVID, who refused immunoglobulin replacement therapy despite plenty of complications. Patient suffered from recurrent respiratory and digestive tract infections, diarrhea, malnutrition, infection of the central nervous system, and autoimmune complications. The complications of untreated hypogammaglobulinemia eventually led to the death of the patient at the age of 63 years. Patients with CVID have an increased susceptibility to chronic infections and subsequent complications; hence, proper treatment with immunoglobulin replacement therapy should be administered. Owing to the increased risk of autoimmunity and malignancy, regular surveillance should be conducted in patients with CVID. Understanding the natural history of untreated hypogammaglobulinemia emphasizes the need for early diagnosis, appropriate treatment, and vigilant follow-up in patients with CVID.
Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel Disease
Kastl, Arthur , Weaver, Kimberly N. , Zhang, Xian , Strople, Jennifer , Adler, Jeremy, Dubinsky, Marla C. , Bousvaros, Athos, Watkins, Runa , Dai, Xiangfeng , Chen, Wenli , Higgins, Peter D R , Bewtra, Meenakshi , Bellaguarda, Emanuelle, Chun, Kelly , Zikry, Michael, Bastidas, Monique , Firestine, Ann M. , Craig, Riley, Boccieri, Margie , Long, Millie D. , Kastl, Arthur J , Farraye, Francis A , Long, Millie D , Kappelman, Michael D , Brenner, Erica J. , Adler, Jeremy, Cross, Raymond K. , Ungaro, Ryan C. , Farraye, Francis A. , Kappelman, Michael D.

Inflammatory Bowel Diseases | October 16, 2024 | Volume: 31 | Issue: 7 | Pages: 1797-1805

10.1093/ibd/izae225 | PMID 39412147 Get It

Abstract Background Children with inflammatory bowel disease (IBD) may have diminished serologic response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and increased risk for subsequent severe coronavirus disease 2019 (COVID-19) infection. We sought to describe outcomes among those who developed SARS-CoV-2 infection following vaccination, characterize SARS-CoV-2 antibodies 1 year post-vaccination, and identify factors associated with durable serologic response. Methods We recruited children with IBD who received ≥2 doses of SARS-CoV-2 vaccine and prospectively collected data on (1) demographics, IBD characteristics, and therapy and (2) SARS-CoV-2 vaccination, testing, and infection symptoms. Serum was obtained for measurement of anti-receptor-binding domain IgG antibodies following a 2-part immunization at 12 and 52 weeks. Results We enrolled 298 participants (mean age 11.9 ± 3.82, 50% female, 67% Crohn’s disease). Symptomatic COVID-19 infection after vaccination occurred in half of the participants, although only 2 (1%) required hospitalization. Anti-tumor necrosis factor alpha (TNF-α) was associated with higher likelihood of symptomatic COVID-19 infection, with an adjusted hazard ratio of 2.7 (95% CI, 1.5-5.0; P = .001). Nearly all participants (99%) had detectable antibody at Week 52. Children aged 1-5 years had lower 52-week antibody level compared to older children (P = .04), as did those on anti-TNF-α therapy (P = .007) and those who received only 2 vaccine doses prior to Week 52 (P < .001). Conclusions SARS-CoV-2 vaccination provides lasting serologic response and protection against severe COVID-19 for most children with IBD, despite the use of lower vaccine doses in younger children and wide-ranging classes of immunosuppressive therapies.
Gábor Transform-Based Antibody Quantitation in Serum: An Interlaboratory Liquid Chromatography/High-Resolution Mass Spectrometry Investigation
Meldrum, Kayd L., Swansiger, Andrew K. , Koscho, Jacob, Miller, Lily, Sausen, John , Maus, Anthony , Ladwig, Paula M. , Prell, James S. , Maus, Anthony D , Willrich, Maria A V, Prell, James S , Miller, Lily, Willrich, Maria Alice V.

Analytical Chemistry | October 16, 2024 | Volume: 96 | Issue: 43 | Pages: 17413-17422

10.1021/acs.analchem.4c04470 | PMID 39412157 Get It

Comparison of nanoimaging and nanoflow based detection of extracellular vesicles at a single particle resolution
Xu, Shihan , Zhang, Zhengrong , Melvin, Bridgette, Ray, Nibedita Basu, Ikezu, Seiko , Ikezu, Tsuneya , Melvin, Bridgette C, Basu Ray, Nibedita, Ikezu, Tsuneya

Journal of Extracellular Biology | October 16, 2024 | Volume: 3 | Issue: 10 | Pages: No page available

10.1002/jex2.70016 | PMID 39416671 Get It

AbstractThe characterization of single extracellular vesicle (EV) has been an emerging tool for the early detection of various diseases despite there being challenges regarding how to interpret data with different protocols or instruments. In this work, standard EV particles were characterized for single CD9+, single CD81+ or double CD9+/CD81+ tetraspanin molecule positivity with two single EV analytic technologies in order to optimize their EV sample preparation after antibody labelling and analysis methods: NanoImager for direct stochastic optical reconstruction microscopy (dSTORM)‐based EV imaging and characterization, and Flow NanoAnalyzer for flow‐based EV quantification and characterization. False positives from antibody aggregates were found during dSTORM‐based NanoImager imaging. Analysis of particle radius with lognormal fittings of probability density histogram enabled the removal of antibody aggregates and corrected EV quantification. Furthermore, different machine learning models were trained to differentiate antibody aggregates from EV particles and correct EV quantification with increased double CD9+/CD81+ population. With Flow NanoAnalyzer, EV samples were prepared with different dilution or fractionation methods, which increased the detection rate of CD9+/CD81+ EV population. Comparing the EV phenotype percentages measured by two instruments, differences in double positive and single positive particles existed after percentage correction, which might be due to the different detection limit of each instrument. Our study reveals that the characterization of individual EVs for tetraspanin positivity varies between two platforms—the NanoImager and the Flow NanoAnalyzer—depending on the EV sample preparation methods used after antibody labelling. Additionally, we applied machine learning models to correct for false positive particles identified in imaging‐based results by fitting size distribution data.
High Ki67 index is associated with shorter progression free survival in patients with Follicular Lymphoma treated with frontline immunochemotherapy
Han, Jianmin, Isom, Scott , Smith, Wesley, Begley, Stephanie, Jenneman, Dakota, Bose, Rupali, Seegars, Mary Beth, McCall, Chad M. , Hsi, Eric D. , Ghosh, Nilanjan

Leukemia & Lymphoma | October 16, 2024 | Volume: 66 | Issue: 2 | Pages: 325-328

10.1080/10428194.2024.2414899 | PMID 39411845 Get It

NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024
Cohen, Joshua G. , Miller, David S. , Robertson, Sharon E. , Hendrickson, Andrea Wahner, Gray, Heidi J. , Hakam, Ardeshir, Jain, Angela, Konecny, Gottfried E. , Moroney, John W. , Ratner, Elena , Schorge, John O., Werner, Theresa L. , Chen, Lee-may, DeRosa, Marie, Eisenhauer, Eric , Leiserowitz, Gary S. , Litkouhi, Babak , McHale, Michael , Percac‐Lima, Sanja , Rodabaugh, Kerry J. , Vargas, Roberto , Jones, Frankie, Kovách, E, Hang, Lisa E., Ramakrishnan, Swathi , Armstrong, Deborah K. , Miller, David S , Liu, Joyce F. , Berchuck, Andrew , Backes, Floor , Grisham, Rachel Nicole , Leath, Charles A , Martin, Lainie P. , Matei, Daniela , Barroilhet, Lisa , Uppal, Shitanshu , Gershenson, David M. , Thaker, Premal H. , Zsíros, Emese , Behbakht, Kian , Kovach, Emily, Alvarez, Ronald D.

Journal of the National Comprehensive Cancer Network | October 16, 2024 | Volume: 22 | Issue: 8 | Pages: 512-519

10.6004/jnccn.2024.0052 | PMID 39413835 Get It

The NCCN Guidelines for Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer provide multidisciplinary diagnostic workup, staging, and treatment recommendations for this disease. These NCCN Guidelines Insights detail how the evolution of the use of PARP inhibitors as maintenance and single-agent regimens for the treatment of ovarian cancer informed panel recommendations in the guidelines.
Medical Therapies for Prevention and Treatment of Inflammatory Pouch Disorders—A Systematic Review and Meta-Analysis
Syal, Gaurav , Barnes, Edward L. , Raffals, Laura E. , Kazzi, Elie S. Al , Haydek, John P. , Agrawal, Manasi , Singh, Siddharth , Barnes, Edward L , Al Kazzi, Elie , Haydek, John

American Journal of Gastroenterology | October 16, 2024 | Volume: 120 | Issue: 1 | Pages: 135-150

10.14309/ajg.0000000000003136 | PMID 39466277 Get It

INTRODUCTION: Pouchitis and Crohn's-like disease of the pouch (CLDP) are common in patients who undergo ileal pouch anal anastomosis for ulcerative colitis. We conducted separate systematic reviews to evaluate the effectiveness of available interventions to prevent and treat pouchitis and CLDP. METHODS: Through systematic literature reviews, we identified studies that evaluated the effectiveness of probiotics, antibiotics, 5-aminosalicylates, nonsystemic oral corticosteroids, and advanced therapies for prevention and treatment of pouchitis and CLDP for meta-analysis. Primary outcomes were occurrence of pouchitis for pouchitis prevention and clinical response for pouchitis and CLDP treatment. We estimated the relative effectiveness of these interventions using the existing placebo response rates or hypothetical spontaneous improvement rates derived from clinical trials of pouchitis, ulcerative colitis, and Crohn's disease. RESULTS: Probiotics were effective for primary (relative risk [RR] 0.18; 95% confidence interval [CI] 0.05–0.62) and secondary prevention (RR 0.17; 95% CI 0.09–0.34) of pouchitis. Antibiotics were effective for treatment of acute and chronic pouchitis (12 cohorts; RR 1.67; 95% CI 1.34–2.01; response rate 65%; 95% CI 52–75) with ciprofloxacin and metronidazole-based regimens being more effective than rifaximin. Advanced therapies were effective for treatment of chronic antibiotic-refractory pouchitis (31 cohorts; RR 1.71; 95% CI 1.28–2.56; response rate 50%; 95% CI 43–57) and CLDP (10 cohorts; RR 2.49; 95% CI 1.87–3.73; response rate 74%; 95% CI 68–79) without significant difference between classes. DISCUSSION: Multiple medical interventions are effective for prevention and treatment of pouchitis and CLDP. Given the overall low quality of data, further research is needed to confirm these findings.
Global health training opportunities during pediatric hematology/oncology fellowship: Results from a survey of program leaders
Hornstein, Paula, Falade, Ayo , Lehmann, Leslie , Fadelu, Temidayo , Falade, Ayo S , Fadelu, Temidayo A , Triedman, Scott A.

Pediatric Blood & Cancer | October 16, 2024 | Volume: 72 | Issue: 1 | Pages: No page available

10.1002/pbc.31375 | PMID 39410798 Get It

AbstractBackgroundThere is growing interest in global health (GH) among medical trainees in the United States. However, providing GH training opportunities at the fellowship level presents several challenges. Understanding of barriers and facilitators to implementing GH training is essential for addressing these challenges.MethodsWe developed a comprehensive survey of 65 Likert‐scale multiple‐choice and open‐ended questions to assess perspectives of pediatric hematology/oncology fellowships leaders on GH training. The survey was electronically distributed to program leaders at all ACGME‐accredited pediatric hematology/oncology fellowships programs, and data were summarized using descriptive analysis.ResultsOf 73 eligible programs, we had a 45.2% response rate with 27 complete and 6 partial responses. Respondents represented programs across the United States, including 19 (57.6%) affiliated with NCI‐Designated Cancer Centers. Fourteen programs (43.8%) currently offer GH training opportunities, whereas 18 programs expressed interest in future opportunities (15, 83.3%) or plan to offer them soon (3, 16.7%). Major barriers identified include competing training priorities (23, 82.1%), lack of faculty mentors in the division (23, 82.1%), and lack of dedicated institutional funding (20, 71.4%). Key facilitators include the interest and initiative of current fellows (27, 96.4%), dedicated institutional funding (26, 92.8%), and having established international partnerships (26, 92.8%).ConclusionsThe study reveals strong interest in GH training in pediatric hematology/oncology fellowships. Despite challenges such as competing priorities and a lack of mentors, significant facilitators include current fellows’ initiatives, dedicated funding, and established international partnerships. These insights can help shape future initiatives to incorporate GH into pediatric oncology/hematology fellowship training.
Cryoablation for unresectable unicentric Castleman disease
Nishimura, Yoshito , Atwell, Thomas D. , Callstrom, Matthew R. , Howard, Matthew T., King, Rebecca L. , Atwell, Thomas, Callstrom, Matthew, McGarrah, Patrick , Howard, Matthew, Dispenzieri, Angela , Nishimura, Yoshito , McGarrah, Patrick W. , Dispenzieri, Angela

American Journal of Hematology | October 16, 2024 | Volume: 100 | Issue: 1 | Pages: 149-151

10.1002/ajh.27507 | PMID 39411984 Get It

A review of acute symptomatic seizures during awake craniotomy for tumour resection
Freund, Brin , Barrios, M. A. , Sabsevitz, David S. , Middlebrooks, Erik H. , Sánchez-Garavito, Jesús E. , Tatum, William O. , Barrios, Maria L, Feyissa, Anteneh M. , Middlebrooks, Erik H , Barrios, Maria L., Grewal, Sanjeet S. , Freeman, William D. , ReFaey, Karim

British Journal of Neurosurgery | October 16, 2024 | Volume: 40 | Issue: 1 | Pages: 9-14

10.1080/02688697.2024.2410774 | PMID 39411925 Get It